# Filing Detail

Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405]:
SEC Accession No. 0001641172-25-000925
Filing Date
2025-03-27
Accepted
2025-03-27 16:05:50
Documents
119
Period of Report
2024-12-31

Document Format Files

Seq | Description | Document | Type | Size
--- | --- | --- | --- | ---
1 |  | form10-k.htm iXBRL | 10-K | 2088614
2 |  | ex10-45.htm | EX-10.45 | 20912
3 |  | ex19.htm | EX-19 | 105662
4 |  | ex21-1.htm | EX-21.1 | 7352
5 |  | ex23-1.htm | EX-23.1 | 5537
6 |  | ex23-2.htm | EX-23.2 | 4572
7 |  | ex31-1.htm | EX-31.1 | 17023
8 |  | ex31-2.htm | EX-31.2 | 17004
9 |  | ex32-1.htm | EX-32.1 | 7614
10 |  | ex32-2.htm | EX-32.2 | 7353
11 |  | ex10-45_001.jpg | GRAPHIC | 14023
12 |  | ex19_001.jpg | GRAPHIC | 16310
| Complete submission text file | 0001641172-25-000925.txt |  | 11743210

Data Files

Seq | Description | Document | Type | Size
--- | --- | --- | --- | ---
13 | XBRL SCHEMA FILE | hrow-20241231.xsd | EX-101.SCH | 79545
14 | XBRL CALCULATION FILE | hrow-20241231_cal.xml | EX-101.CAL | 107157
15 | XBRL DEFINITION FILE | hrow-20241231_def.xml | EX-101.DEF | 408929
16 | XBRL LABEL FILE | hrow-20241231_lab.xml | EX-101.LAB | 706662
17 | XBRL PRESENTATION FILE | hrow-20241231_pre.xml | EX-101.PRE | 588408
122 | EXTRACTED XBRL INSTANCE DOCUMENT | form10-k_htm.xml | XML | 1901281

Mailing Address 102 WOODMONT BLVD SUITE 610 NASHVILLE TN 37215
Business Address 102 WOODMONT BLVD SUITE 610 NASHVILLE TN 37215 615.733.4731
HARROW, INC. (Filer) CIK: 0001360214 (see all company filings)

EIN.: 450567010 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-K | Act: 34 | File No.: 001-35814 | Film No.: 25779285
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)